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Abstract
Background: Research on the sexual networks of transwomen is central to explaining higher HIV risk for this
population. This study examined HIV risk behaviors and sexual mixing patterns of transwomen by demographic and
HIV-related risk behaviors.
Methods: Data were obtained from a 2010 study of HIV risk for transwomen in San Francisco. Assortativity by race,
partner type, HIV serostatus, and IDU across sexual networks was calculated using Newman’s assortativity
coefficient (NC). Multivariable generalized estimating equations (GEE) logistic regression models were used to
evaluate associations between unprotected anal intercourse with race and HIV serostatus, partner-IDU status and
relationship type discordance while adjusting for the HIV status of transwomen.
Results: There were 235 sexually active transwomen in this study, of whom 104 (44.3%) were HIV-positive and 73
(31.1%) had a history of injection drug use. Within the 575 partnerships, African American/black and Latina
transwomen were the most racially assortative (NC 0.40, 95% CI 0.34-0.45, and NC 0.43, 95% CI 0.38-0.49, respectively).
In partnerships where the partner’s HIV status was known (n = 309, 53.7%), most transwomen were in sexual
partnerships with people of their same known serostatus (71.8%, n = 222). In multivariable analyses, unprotected
anal intercourse was significantly associated with primary partners, having a sexual partner who was an injection
drug user, and sexual partner seroconcordance.
Conclusions: Public health efforts to reduce transwomen’s HIV risk would likely benefit from prioritizing
prevention efforts to risk reduction within IDU-discordant and primary partnerships, determining risks attributable
to sexual network characteristics, and actively addressing injection drug use among transwomen.
Background
A systematic review of HIV research in the US found
that transgender women (transwomen) engage in high
rates of unprotected receptive anal intercourse, which
may explain elevated rates of HIV [1]. Findings from
epidemiological research on HIV suggests that members
engaging in serodiscordant partnering, or sex between
partners with different HIV statuses, is key to maintain-
ing and transmitting HIV within populations at risk and
their sexual partners [2]. Past studies of transwomen
have found that sexual risk behavior is highest in primary
sexual partnerships [3-5]. However, one recent study
found that risk for HIV was highest for transwomen who
did sex work, possibly due to the higher volume of sexual
partnerships by choice or by assault that increased
chances for exposure to HIV [6]. Transwomen have also
been found to be more likely than other populations at
risk for HIV to have serodiscordant partnerships,
though partner serodiscordance did not significantly
influence engagement in unprotected receptive anal
intercourse [7]. HIV risk may, in part, be explained by
the behaviors specific to particular partner types and
the serostatus of those partners.
Transwomen may also be at risk for HIV due to sub-
stance use. A number of studies have demonstrated
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elevated use of illicit drugs among transwomen [1,8]. A
recent population-based study of transwomen found
that testing positive for HIV was significantly related to
methamphetamine use, methamphetamine use before
or during anal intercourse, and at least weekly metham-
phetamine use [9]. Concerns about HIV transmission
via injection drug use among transwomen have been re-
lated to needle sharing practices, injection of hormones
or other fillers (i.e. illicit “silicone”) and injection drug
use behaviors of sexual partners [10-12]. Risk related to
injection hormones is mixed as one study found that a
combination measure of injection drug and hormone
use to be related to self-reported HIV infection, while
another recent study of injection of fillers (i.e. illicit
substances used to feminize transwomen’s appearance)
found no association with an HIV positive test [8,13]. A
population-based study of transwomen in San Francisco
found that 32.5% had ever injected substances not pre-
scribed by medical professionals and 11.8% had injected
in the past 12 months [14]. In the same study, injection
drug use in the past 12 months was one of only three
factors that remained significantly associated with HIV
infection. Transwomen who inject drugs may be at high
risk for HIV from non-sterile injection equipment, and
from sexual transmission, as this mode of transmission
accounts for a substantial number of incident infections
in some studies [15,16]. However, data are missing on
HIV risk related to sex with injection drug users among
transwomen, thus it is difficult to discern whether IDU-
related risk among transwomen is due to injection drug
use practices of transwomen, their sexual partners who
are IDU, or both.
By comparison, race has been an important sexual
mixing factor as it relates to HIV risk among MSM [17].
Bohl et. al’s [17] article on racial disparities in HIV found
that the sexual networks of African American/black MSM
account for their higher prevalence of HIV compared with
non-African American/black MSM. This study provided
compelling evidence that sexual networks rather than in-
dividual characteristics or behaviors explained significantly
higher risk of HIV for African American/black MSM [17].
The systematic review of HIV among U.S. transwomen
found that the weighted mean HIV prevalence for African
American/blacks was 56.3%, which was almost twice as
high as that found among White or Hispanic transwomen
[1]. An important next step in the investigation of HIV
risk for transwomen is to better understand risk via their
sexual networks. To fill a void in what we know about
the sexual partnerships of transwomen, we conducted
an analysis of demographic and risk factors of the sexual
networks of sexually active transwomen in San Francisco.
We also evaluated which sexual mixing factors by race,
partner type, IDU status, and HIV status were correlated
with HIV-related sexual risk behaviors.
Methods
Respondent-level variables - transwomen participants
Data for this analysis are taken from a study of transgender
women that took place in 2010 (TEACH- the Transgender
Empowerment and Community Health study). Trans-
gender women were recruited using respondent driven
sampling (RDS) in which 11 initial seed participants
recruited a total final sample of 314 transwomen [18].
Individuals were eligible for the study if they (1) self-
identified as transwomen, (2) were age 18 years or older
and (3) reported living in San Francisco. Each study par-
ticipant was screened for study eligibility prior to enroll-
ment. Eleven seeds diverse in respect to race/ethnicity,
income, education, and age were selected as the initial
recruits. Recruits could be anyone in their social net-
work who seeds (or recruiters) thought was eligible for
the study. All participants were remunerated $10 for
recruiting peers who were eligible and enrolled into the
study (see Rapues et al., 2013 for more information on
seeds). All data on HIV status were collected by either
self-report and/or through an HIV assay. Respondents
who were HIV-positive were able to refuse the HIV test
with no repercussions for receiving an incentive.
Participants were asked to report on up to 5 sexual
partners from the past six months, including each part-
ner’s age, gender identity, race/ethnicity, what type of part-
ner each person was (i.e. primary, casual or commercial),
where the participant met each partner, sexual behavior,
HIV status and whether that person was an injection drug
user. We created a dataset of all the sexual partnerships of
TEACH participants for the past six months. Those that
did not report having a sexual partner in the last six
months, those with missing data on HIV-serostatus, and
those who were HIV-positive but with an unknown posi-
tive status at the time of participation were excluded from
this analysis.
Statistical analysis
We analyzed sexual partner mixing by race, HIV seros-
tatus, and explored partner-level characteristics includ-
ing relationship type and IDU status. Consistent with
surveillance and other sexual mixing studies, partner
data analyzed for this study are egocentric and therefore
based solely on data reported by transwomen participants,
not from their partners [19]. Sexual risk in TEACH was
assessed by asking a number of questions about character-
istics and behaviors of the last 5 sexual partners of trans-
women and by asking transwomen what sexual behaviors
they engaged in with each of these partners. This strategy
is employed nationally in the U.S. and in global HIV sur-
veillance efforts to enhance recall and obtain specificity
in recent sexual behaviors of populations most at risk
for HIV [20].
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Transwomen were also asked to identify the race, HIV
status, and injection drug use status of their last 5 sexual
partners. Partner types were categorized as main, casual
and commercial. Main partners were defined as, “some-
one who is your primary sexual partner and you feel
committed to (boyfriend, lover, husband, girlfriend,
wife)”. Casual partners were defined as, “someone you
have sex with, but don’t feel committed to or don’t
know very well”. Commercial partners were defined as,
“someone you had sex with in exchange for things like
money or goods”.
Sexual mixing in HIV status or serodiscordance was
defined as a difference in reported or tested HIV status
of the transwomen participant and the reported HIV
status of the sexual partner, as has been done in studies
of MSM [21,22]. We excluded 47 partnerships where the
HIV status of the transwoman participant was unknown.
In the case that a transwoman participant was HIV posi-
tive and reported her partner’s HIV status as negative,
and vice versa for a transwoman who was HIV-negative
and reported her partner as being HIV-positive, the part-
nership was categorized as serodiscordant. Transwomen’s
partnerships with those of an unknown HIV status were
also categorized as serodiscordant, consistent with prior
literature [23,24]. We calculated assortativity by race, part-
ner status (main, casual, or commerical), HIV serostatus,
and IDU between transwomen and their sexual networks
using Newman’s assortativity coefficient. Newman’s assorta-
tivity coefficients ranges from −1 to 1; negative coefficients
correspond with disassortativity or a higher-degree of mix-
ing, while positive coefficients correspond with assortativity
or a lower-degree of mixing [25]. A study of MSM in San
Francisco over three waves of data collection from 2004–
2011 found slightly assorative mixing by race overall at
r = 0.08 in 2004, but highly assortative partnering for
African Americans/blacks (r = 0.44) [26]. Based on this
study and the work of Doherty et al. [27], we have catego-
rized mixing coefficient values ≥ 0.35 as assortative, 0.15–
0.34 as moderately assortative, and < 0.15 as disassortative.
Multivariable analysis of engagement in sexual risk
behavior
In the primary outcome multivariable analysis, we evalu-
ated the associations between UAI with sexual partners
and discordance in race and HIV serostatus, as well as
partner-IDU status and relationship type, while adjusting
for the HIV status of transwomen. We used multivariable
generalized estimating equations (GEE) logistic regression
models that accounted for correlation between the mul-
tiple partnerships of each study participant to estimate
odds ratios and 95% confidence intervals.
Analyses were conducted using STATA 12.0. Data ad-
justments to make inference to the population from
which the sample was drawn were not made because the
sample was stratified for this analysis and the exclusion
of 79 participants eliminates the ability to assure equilib-
rium in the sample. Therefore, findings from this study
describe findings from this dataset alone and may not be
generalizable to the San Francisco transwoman popula-
tion overall.
This study received human participants review and ap-
proval from the University of California, San Francisco’s
Committee on Human Research.
Results
Participants demographics
Of the 314 TEACH participants, 15 refused to take an
HIV test and 64 did not have any sexual partners in the
past six months, thus leaving 235 transwomen for our
analysis. Among these sexually active transwomen 44.3%
(n = 104) were HIV-positive (Table 1). Of the 235 sexually
active transwomen, 72.3% (n = 170) reported having five
or fewer sexual partners. The range of sexual partnerships
per transwomen was 1–500, with a median number of
three (inter-quartile range [IQR]: 1–6) sexual partners and
a mean of 11 (standard deviation: 39.01). However, not
all sexual partnerships were included in this analysis as
participants were only asked about characteristics of up
to five individual sexual partners. Within this dataset, a
respondent may have had her data repeated, but each
partnership was unique.
Over 60% of the sample was transwomen who were
either Latina (30.6%) or African American/black (31.1%).
Whites made up 15.3% of the sample, 16.6% were
“Other” and only 6.4% of our sample was Asian or
Pacific Islander (API). Transwomen split almost evenly
into identifying as transgender or female (52.3% and
47.7%, respectively). The median age of transwomen in
this analysis was 42 (IQR 32–48) and the mean was 41
(SD 10.7). Most transwomen did not have a lifetime his-
tory of IDU (n = 162, 68.9%), but a sizeable proportion
did report being IDU (n = 73, 31.1%).
Partners demographics
There were a total of 575 partnerships analyzed from
the 235 sexually active transwomen respondents. The
characteristics of these partners are summarized in
Table 1. Most partners of transwomen were between the
ages of 26–43 (50%). The mean age of partners was 34.8
(SD 15). The majority of partnerships were with men
(n = 537, 93.4%), and the most common place where
transwomen met their sexual partners was on the street
(n = 225, 39.1%). The majority of sexual partnerships were
casual (n = 322, 56%), while 26.3% (n = 151) were with pri-
mary partnerships and 17.7% (n = 102) were commercial
relationships.
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Sexual partners and mixing
HIV
Among transwomen with a known HIV status, almost
half of transwomen’s sexual partnerships were with part-
ners of an unknown HIV status (46.3%, n = 266). Of
those who knew their partner’s HIV status (n = 309,
53.7%), transwomen were in more sexual partnerships
with people of their same known serostatus (36.5%,
n = 222). Among sexual partners of transwomen with
a known HIV serostatus, the Newman’s coefficient was
0.40 (0.33-0.47), suggesting that transwomen were assorta-
tive in their sexual partnering with people of the same ser-
ostatus. Excluding partnerships where the HIV status was
unknown for partners (n = 266), 25% of partnerships were
between HIV-positive transwomen and HIV-negative part-
ners (n = 78, 24.3%). Only 3% of partnerships were be-
tween HIV-negative transwomen and an HIV-positive
sexual partner (n = 9).
IDU
Most transwomen did not ever inject drugs, though a
sizeable portion did inject drugs (n = 73, 31.1%). Similarly,
most transwomen reported that their partners did not inject
drugs (n = 520, 90.4%), while 9.6% of partners (n = 55) re-
portedly did inject drugs. The Newman’s assortativity coef-
ficient for IDU was 0.23 (95% CI 0.19- 0.26), suggesting
that transwomen were moderately more likely to partner
with people of the same IDU status. Sexual partnerships
where non-IDU transwomen had partners who were IDU
Table 1 Characteristics of sexually active transwomen
participants (n = 235) and their sexual partners in the last
6 months (n = 575)
Transwomen participant demographics
and behaviors
n mean (%) (SD)





African American/black 73 (31.1)














Sexual partner demographics and behavior






Other/Did not specify 5 (0.9)
Race/Ethnicity
African American/black 183 (31.8)









On the street, park or public place 225 (39.1)
Introduced by friends 67 (11.7)
Internet 62 (10.8)
Table 1 Characteristics of sexually active transwomen
participants (n = 235) and their sexual partners in the last










Same HIV-status as participant
No 353 (61.4)
Yes 222 (38.6)
Same race as participant
No 365 (36.5)
Yes 210 (63.5)
Unprotected Anal Intercourse with participant
No 452 (78.6)
Yes 123 (21.4)
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made up 13% of IDU-discordant partnerships (n = 19),
while sexual partnerships where IDU transwomen had
non-IDU partners made up the other 87% (n = 123).
Therefore, more transwomen were IDUs in sexual part-
nerships where IDU status was mixed.
Race
The majority of sexual partners of transwomen were White
(195 of 575 partners; 33.9%), African American/black (183
of 575 partners; 31.8%), or Latino (134 of 575; 23.3%)
(Table 1). However, when assessing partnerships on a race-
by-race basis, African-American/black, Latino, and White
transwomen most commonly reported having sexual part-
ners of the same race. Sexual partners of White trans-
women were 47% White (n = 43), followed by African-
American/black 26% (n = 24), and Latino 13% (n = 12).
Sexual partners of African-American/black transwomen
were 60% African-American/blacks (n = 106), followed by
White 29% (n = 40) and Latino 8% (N = 15). Sexual part-
ners of Latino transwomen were 49% Latino (n = 100),
followed by white 26% (n = 53) and African-American/
black 11% (n = 24). The overall Newman’s assortativity
coefficient for race was .26 (95% CI 0.22-0.30), suggest-
ing that transwomen were moderately assortative by
race. When distilled by race, the assortativity coefficient
by Asian race was 0.03 (95% CI 0.01-0.05), by African
American/black was 0.40 (95% CI 0.34-0.45), by Latino
was 0.43 (95% CI 0.38-0.49) and by White was 0.11
(95% CI 0.06-0.15). Thus, African American/black and
Latina transwomen were more assortative than Whites
and Asians, and had sexual partners of the same race
more often that transwomen of other races.
Prevalence and multivariate analysis of engagement in
sexual risk behavior
Among transwomen, 88 (37.5%) reported having UAI
with at least one sexual partner. Transwomen reported
having UAI in 123 sexual partnerships (21.4% of 575
partners). The results of the GEE multivariable logistic
regression model examining the association of sexual
mixing factors with unprotected anal sex are summa-
rized in Table 2. Results indicate that compared to pri-
mary partners, transwomen had an adjusted odds of UAI
that was 0.23 (95% CI 0.15-0.36, p < 0.001) and 0.20 (95%
CI 0.10-0.43, p < 0.001) lower with casual and commercial
partners, respectively. Moreover, transwomen had an ad-
justed odds of UAI of 0.55 (95% CI 0.35-0.87, p < 0.001)
lower with HIV serodiscordant partners compared to
seroconcordant partners. In addition, transwomen had
an adjusted odds of UAI that was 2.66 (95% CI 1.43-
4.97, p < 0.001) greater with sexual partners who were
IDU than with non-IDU. The odds of engaging in UAI
were not significantly different between same race and
different race partners of transwomen (aOR 0.77, 95%
CI 0.50-1.21, p = .40).
Discussion
The goal of this analysis was to determine if there were
significant sexual mixing patterns in addition to individ-
ual risk behaviors to help understand high HIV risk
among transwomen. In the final analysis we found that
UAI was significantly associated with having a sexual
partner who was an injection drug user, primary partner,
and/or HIV seroconcordant. Transmission of HIV from
injection drug users to sexual partners who are uninfected
may be a source of HIV risk for transwomen. Sexual trans-
mission of HIV from seropositive IDUs to non-injecting
sexual partners is extremely likely, and more risky than
that associated with sharing needles [25]. In this study,
only 10% of partners were IDU, but that represented 55
sexual encounters for transwomen, thus mixing with indi-
viduals who are injection drug users remains an important
area of investigation for understanding transwomen’s risk
for HIV.
Table 2 Prevalence and Multivariable GEE logistic regression model on Partner-level correlates of Unprotected
Anal Intercourse
UAI with partners Crude Adjusted*
No (%) Yes (%) OR 95% CI P-value AOR 95% CI P-value
Partner Characteristics
Same race partners 252 (74.1) 88 (25.9) 1 - - 1 -
Different race partners 200 (85.1) 35 (14.9) 0.80 0.54-1.20 0.28 0.77 0.50-1.21 0.26
Primary partner 87 (57.6) 64 (42.4) 1 - - 1 - -
Casual partner 279 (86.6) 43 (13.4) 0.21 0.13-0.32 <0.001 0.23 0.15-0.36 <0.001
Commercial partner 86 (84.3) 16 (15.7) 0.18 0.09-0.37 <0.001 0.20 0.10-0.43 <0.001
Non-IDU partners 420 (80.8) 100 (19.2) 1 - - 1 - -
IDU partners 32 (58.2) 23 (41.8) 2.44 1.37-4.33 0.002 2.66 1.43-4.97 0.002
HIV seroconcordant partners 154 (69.4) 68 (30.6) 1 - - 1 -
HIV serodiscordant partners 298 (84.4) 55 (15.6) 0.43 0.29-0.64 <0.001 0.55 0.35-0.87 0.01
Notes: *Model adjusted for participant-level characteristics in table above and individual-level co-variables (e.g. Age and HIV-status of TEACH participant). GEE
models adjusted for clustering of partner-level data by TEACH participant.
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These data also support prior studies that have shown
higher rates of UAI within primary partnerships [3,4]. Of
all three partner types - primary, casual and commercial -
primary partners have consistently been the type in which
transwomen engage in the highest risk behavior, which is
consistent with the literature for MSM, IDU and hetero-
sexual men and women [3,4,28-32]. Yet transwomen in
this analysis were also less likely to engage in UAI with
serodiscordant partners. Many of the partnerships ana-
lyzed as serodiscordant were those in which transwomen
did not know the HIV status of their sexual partner, which
made up almost of half of sexual partnerships. The finding
on partnerships of unknown HIV status is higher than
recent research with Peruvian transwomen and MSM
showing that one quarter of partners were people of un-
known serostatus [33]. Yet findings that transwomen
were significantly less likely to engage in UAI with partners
of a different serostatus is consistent with other research
findings [7], and may also be a sign that transwomen are
serosorting. Available data on the effects of serosorting on
HIV transmission are equivocal; some studies suggest pro-
tective benefits [34], while some have found increased risk
for transmission due to serosorting [12]. Given the dispro-
portionate impact of HIV among transwomen, it would be
prudent to inform transwomen about possible limitations
of serosorting in reducing HIV risk. Also different, most
serodiscordant partnerships in our study were character-
ized by transwomen living with HIV. As has been found
in research with HIV-positive MSM, transwomen already
living with HIV many may be choosing HIV-negative part-
ners to protect from super-infection and other sexually
transmitted diseases [35]. Alternatively, this finding may
represent the overall high prevalence of HIV among trans-
women and the high likelihood of having a HIV-negative
partner.
One risk we did not observe in this study was an asso-
ciation between same race sexual partnerships and risk
for HIV via elevated rates of engagement in UAI. Highly
interconnected networks among African American/black
MSM have been a driver of HIV in the population
[1,14,36]. African American/black transwomen have al-
most twice the rate of HIV as the overall transwomen
population [18]. Assortativity was significantly higher
for African American/black and Latina participants and
engagement in UAI was not significantly different. Thus,
findings of assortativity on race alone may mean highly
interconnected sexual networks with those of their same
racial/ethnic identities are important for understanding
higher HIV risk among African American/black and Latina
transwomen. Given the lack of significant differences in en-
gagement in sexual risk behavior, this study provides evi-
dence that same-race partnerships may be a driver of HIV
risk for transwomen. More work needs to be done to see if
transwomen are facing the same risks for HIV as African
American/black MSM that was attributed to sexual net-
works despite low engagement in sexual risk behaviors.
Finally, data from this analysis point to a diversity of
transwomen’s choices in sexual partners by race. Though
the largest proportion of sexual partners were the same
race as the transwomen participants, up to 70% of part-
ners were of a different race. The only known study of
the main male partners of transwomen in which a con-
venience sample was used to recruit participants found
mostly African American/black male partners [37]. The
difference in findings on the race of sexual partners be-
tween studies may be due to the population-based sam-
pling conducted for this study that points to diverse rather
than limited sexual mixing patterns among transwomen
overall.
There are a number of limitations to this study. Data
were gathered based on self-report, which may be inher-
ently biased due to social desirability. Demographic and
behavioral factors of sexual partners were also reported by
transwomen respondents and not the partners themselves.
Therefore, the characteristics and behaviors of sexual
partners may be inaccurate due to biases of the partici-
pant, inaccurate knowledge and recall bias. Though
these data are taken from a study employing respondent
driven sampling, the exclusion of participants who did
not recently have a sexual partner may make these data
less generalizable to the overall transwoman population
in San Francisco.
Conclusions
These data point to important next steps in research
and prevention. Past prevention research has mostly tar-
geted transwomen, and these data suggest that serving
one side of the risk equation may not be enough to curb
the epidemic within this hard hit population [38]. In-
deed, it may be the lack of prevention resources provided
to the sexual partners of transwomen that has contributed
to the persistent high risk for HIV among transwomen, thus
prevention messaging must be designed and targeted to
sexual partners too. Research to better understand the con-
siderations of transwomen when selecting sexual partners,
such as the convergence with IDU sexual networks, may
contribute to more targeted HIV and IDU prevention and
harm reduction strategies that impact transwomen’s own
drug use behavior and selection of partners who are IDUs
[11]. Interventions that work with transwomen to identify
ways to ask about the serostatus of their sexual partners are
also warranted. Serosorting is only protective when two
individuals can make safe sex decisions based on known
HIV status. The promise of home testing and instant
HIV testing may help further such efforts and should be
considered for distribution among transwomen and for
their sexual partners. Finally, future longitudinal research
with transwomen is also needed so analyses can better
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determine risks among incident cases instead of ex-
trapolating findings from cross sectional data within
high prevalence samples.
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